These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables. Barstad B, Tveitnes D, Dalen I, Noraas S, Ask IS, Bosse FJ, Øymar K. Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360 [Abstract] [Full Text] [Related]
9. Point-of-care testing for CXCL13 in Lyme neuroborreliosis. Pietikäinen A, Oksi J, Hytönen J. Diagn Microbiol Infect Dis; 2018 Jul; 91(3):226-228. PubMed ID: 29567125 [Abstract] [Full Text] [Related]
10. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study. Remy MM, Schöbi N, Kottanattu L, Pfister S, Duppenthaler A, Suter-Riniker F. J Neuroinflammation; 2017 Aug 31; 14(1):173. PubMed ID: 28859668 [Abstract] [Full Text] [Related]
16. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children. Barstad B, Tveitnes D, Noraas S, Selvik Ask I, Saeed M, Bosse F, Vigemyr G, Huber I, Øymar K. Pediatr Infect Dis J; 2017 Dec 31; 36(12):e286-e292. PubMed ID: 28661964 [Abstract] [Full Text] [Related]
17. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. Ljøstad U, Mygland A. J Neurol; 2008 May 31; 255(5):732-7. PubMed ID: 18344056 [Abstract] [Full Text] [Related]